During the past decade, Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia" are "Crohn Disease" (2 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Alzheimer's Disease" (1 trials) and "Duchenne Muscular Dystrophy" (1 trials). Many other conditions were trialed in "Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia" in a lesser frequency.

Most popular intervention types in "Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Etrolizumab" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Donepezil" (1 trials) and "Galantamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione Policlinico Universitario A Gemelli; Servizio di Farmacia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".